Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial

por Ou, Wei, Li, Ning, Wang, Bao-Xiao, Zhu, Teng-Fei, Shen, Zhi-Lin, Wang, Tao, Chang, Wu-Guang, Chang, Zeng-Hao, Hu, Xin-Xin, Pu, Yue, Ding, Lie-Ming, Wang, Si-Yu
Publicado 2023